Short Interest in Envista Holdings Corporation (NYSE:NVST) Declines By 23.3%

Envista Holdings Corporation (NYSE:NVST) saw a large decrease in short interest during the month of January. As of January 30th, there was short interest totaling 8,087,163 shares, a decrease of 23.3% from the January 15th total of 10,544,812 shares. Based on an average trading volume of 2,580,648 shares, the short-interest ratio is presently 3.1 days. Approximately 5.0% of the shares of the stock are sold short. Approximately 5.0% of the shares of the stock are sold short. Based on an average trading volume of 2,580,648 shares, the short-interest ratio is presently 3.1 days.

Envista Stock Up 0.7%

Shares of NYSE NVST traded up $0.22 during mid-day trading on Friday, reaching $28.99. The company had a trading volume of 2,193,354 shares, compared to its average volume of 3,680,204. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.04 and a current ratio of 2.38. The company has a market capitalization of $4.77 billion, a price-to-earnings ratio of 103.52, a PEG ratio of 1.98 and a beta of 1.01. The stock has a fifty day moving average of $23.71 and a two-hundred day moving average of $21.55. Envista has a 12-month low of $14.22 and a 12-month high of $30.42.

Envista (NYSE:NVST) last released its quarterly earnings data on Thursday, February 5th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.54%. During the same period last year, the firm posted $0.24 EPS. The company’s revenue for the quarter was up 15.0% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, equities research analysts expect that Envista will post 1 EPS for the current year.

Insider Activity at Envista

In related news, SVP Mischa Reis sold 9,675 shares of Envista stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total value of $290,250.00. Following the transaction, the senior vice president directly owned 32,382 shares in the company, valued at $971,460. The trade was a 23.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 0.66% of the company’s stock.

Institutional Trading of Envista

Institutional investors have recently bought and sold shares of the company. Ariel Investments LLC grew its stake in Envista by 1.7% in the second quarter. Ariel Investments LLC now owns 12,355,666 shares of the company’s stock valued at $241,430,000 after purchasing an additional 210,921 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Envista by 0.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 9,628,460 shares of the company’s stock valued at $209,036,000 after buying an additional 90,586 shares in the last quarter. Franklin Resources Inc. grew its stake in shares of Envista by 16.7% in the 2nd quarter. Franklin Resources Inc. now owns 8,956,572 shares of the company’s stock valued at $175,011,000 after buying an additional 1,284,767 shares in the last quarter. Alliancebernstein L.P. increased its holdings in Envista by 34.0% in the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock worth $119,164,000 after buying an additional 1,547,656 shares during the last quarter. Finally, Clarkston Capital Partners LLC raised its position in Envista by 0.4% during the second quarter. Clarkston Capital Partners LLC now owns 4,703,330 shares of the company’s stock valued at $91,903,000 after acquiring an additional 16,583 shares in the last quarter.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on NVST. William Blair raised Envista from a “hold” rating to an “outperform” rating in a research note on Friday, February 6th. Piper Sandler reiterated a “neutral” rating and issued a $25.00 target price (up from $21.00) on shares of Envista in a report on Friday, February 6th. Wall Street Zen upgraded shares of Envista from a “buy” rating to a “strong-buy” rating in a report on Monday, January 26th. Wells Fargo & Company upped their price target on shares of Envista from $21.00 to $26.00 and gave the company an “equal weight” rating in a research report on Friday, February 6th. Finally, Zacks Research upgraded shares of Envista from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 6th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $27.43.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.